A commitment for life

A commitment to quality

Our product is manufactured from the plasma of healthy screened donors attending collection centers in the U.S., which are licensed by the Food and Drug Administration (FDA).

A commitment to safety

Our products are manufactured using US plasma collected by internationally respected and highly regulated blood or plasma collection establishments. Stringent safety and quality standards, alongside state-of-the-art screening and viral removal/inactivation systems, ensure that all BPL blood products can be used with confidence

A commitment to education

BPL is committed to helping our physicians, patients, and families learn about their illness and potential treatments.

A commitment to life

Through our commitment to quality, safety and education, we renew our pledge to enhancing life by enhancing life's defenses.

Welcome to BPL - USA, Inc.

We are committed to provide a continuous supply of reliable, high quality plasma-derived products worldwide, supporting both healthcare professionals and patients every day.
Learn more


Press Release: Bio Products Laboratory Receives European Approval for Coagadex® (Human Coagulation Factor X)
» more


Press Release: Bio Products Laboratory Announces Supply of COAGADEX® Now Available in the United States
» more


Press Release: Bio Products Laboratory Receives FDA approval for Coagadex® (Coagulation Factor X, Human) First-ever FDA-approved treatment for hereditary factor X deficiency
» more


Press Release: Gammaplex® Approved for Use in Pediatric Patients (Gammaplex [Immune Globulin Intravenous (Human) 5% Liquid] Approved in Patients 2 years and Older with Primary Immunodeficiencies
» more


Press Release: FDA Accepts BPL’s Amended BLA Submission for Coagadex® (Coagulation Factor X, Human)
» more


Press Release: Bio Products Laboratory, Ltd. Announces Results from Phase III Registration – Study of its Factor X Coagulation Product
» more